Concepedia

Author

Roya Dadmarz

National Institutes of Health

Also Known As

R D Dadmarz, R Dadmarz, R. Dadmarz, Roya Dadmarz

12

Publications

413

Citations

9

H-Index

25

Concepts

All Affiliations

National Institutes of HealthUniversity College LondonNational Cancer InstituteDana-Farber Cancer Institute
RD

About

Roya Dadmarz is an author at National Institutes of Health specializing in autoimmunity, immunotherapy, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

132

2

Immunology

3

3

132

3

Cell Biology

2

2

74

4

Pathology

1

1

58

5

Autoimmune Disease

1

1

58

Roya Dadmarz

×

8

Publications

383

Citations

8

H-Index

YearCitations

In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.

Douglas J. Schwartzentruber, Sophia S. Hom, Roya Dadmarz,

Journal of Clinical Oncology

1994

158

CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion

Roya Dadmarz, Magdalene K. Sgagias, Steven A. Rosenberg,

Cancer Immunology Immunotherapy

1995

58

Heterogeneity of CLL: high CD23 antigen and αIFN receptor expression are features of favourable disease and of cell activation

Roya Dadmarz, John C. Cawley

British Journal of Haematology

1988

58

Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashion.

Roya Dadmarz, A Ordoubadi, Arnold Mixon,

PubMed

2006

55

Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.

Roya Dadmarz, David Bockstoce, Sidney H. Golub

PubMed

1994

16

Association between clonogenic cell growth and clinical risk group in B- cell chronic lymphocytic leukemia

Roya Dadmarz, SN Rabinowe, SA Cannistra,

Blood

1990

13

Hairy cells possess more interferon receptors than other lymphoid cell types.

Roya Dadmarz, Timothy L. Evans, David S. Secher,

PubMed

1987

13

Association between clonogenic cell growth and clinical risk group in B- cell chronic lymphocytic leukemia

Roya Dadmarz, SN Rabinowe, SA Cannistra,

Blood

1990

12

Page 1